Bone Biologics Corp

BBLG

Company Profile

  • Business description

    Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

  • Contact

    2 Burlington Woods Drive
    Suite 100
    BurlingtonMA01803
    USA

    T: +1 781 552-4452

    https://www.bonebiologics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    2

Stocks News & Analysis

stocks

Netflix: A business that’s nearly flawless

Streaming giant’s stellar results had areas of softness; currency tailwinds drive guidance raise.
stocks

Trump’s US dollar assault is fuelling CBA’s rise

A recent $1 billion investment in CBA by Texas based fund manager expresses concern for the outlook of the USD.
stocks

Insignia Financial: Revised deal still attractive

The offer price is well above our fair value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,982.1019.30-0.21%
CAC 407,850.43106.021.37%
DAX 4024,240.82198.920.83%
Dow JONES (US)45,010.29507.851.14%
FTSE 1009,061.4937.680.42%
HKSE25,668.02129.950.51%
NASDAQ21,020.02127.330.61%
Nikkei 22541,890.49719.171.75%
NZX 50 Index12,814.5920.530.16%
S&P 5006,358.9149.290.78%
S&P/ASX 2008,713.3023.90-0.27%
SSE Composite Index3,599.4417.140.48%

Market Movers